论文部分内容阅读
目的:探讨中药疏肝健脾方配合艾迪注射液治疗晚期肝癌临床疗效及对生存质量和生存时间影响。方法:36例失去手术、介入及化疗机会的原发性肝癌晚期患者,予中药疏肝健脾方配合艾迪注射液治疗。结果:治疗后总有效率25.0%(9/36),总稳定率61.1%(22/36);半年生存率77.8%(28/36),1年生存率52.8%(19/36),2年生存率25.0%(9/36),3年生存率为8.3%(3/36)。结论:中药疏肝健脾方配合艾迪注射液治疗晚期肝癌,不仅改善了肝功能,减轻了临床症状,而且提高了患者的生存质量,从而延长了生存时间。
Objective: To investigate the curative effect of traditional Chinese medicine Shugan Jianpi Recipe combined with Aidi Injection on advanced liver cancer and its effect on quality of life and survival time. Methods: Thirty - six patients with advanced primary liver cancer who lost their surgery, intervention and chemotherapy were treated with Chinese medicine Shugan Jianpi prescription combined with Aidi Injection. Results: After treatment, the total effective rate was 25.0% (9/36), the total stability rate was 61.1% (22/36); the half-year survival rate was 77.8% (28/36); the 1-year survival rate was 52.8% The annual survival rate was 25.0% (9/36) and the 3-year survival rate was 8.3% (3/36). Conclusion: Shuganjianpi Recipe combined with Aidi Injection in the treatment of advanced liver cancer not only improves liver function, relieves clinical symptoms, but also improves the quality of life of patients and prolongs the survival time.